TABLE 3.
Treatments | Liver weight (g/g body weight) | S.G.P.T. (IU/L) | Alkaline phosphatase (ALP) (IU/L) | Aspartate aminotransferase (AST) (U/L) | Serum bilirubin (mg/dl) | Gamma glutamyl transferase (GGT) (units/l) |
G0 | 3.31 ± 0.22B | 37 ± 3.62B | 173 ± 7.54B | 58.33 ± 3.05C | 0.44 ± 0.01B | 5.44 ± 0.21C |
G1 | 3.89 ± 0.1A | 61 ± 6.92A | 218.33 ± 3.05A | 111.67 ± 5.51A | 0.65 ± 0.08A | 7.07 ± 0.26A |
G2 | 3.33 ± 0.19B | 42.67 ± 3.51B | 178.33 ± 8.73B | 72.67 ± 5.85B | 0.53 ± 0.01B | 6.29 ± 0.15B |
G3 | 3.15 ± 0.16B | 41 ± 2.01B | 176.67 ± 8.02B | 64 ± 4.35BC | 0.46 ± 0.01B | 6.15 ± 0.25B |
SEM | 0.1024 | 2.5386 | 4.1533 | 2.7839 | 0.0243 | 0.1285 |
A–CThe values carrying different letters within column are significantly different.
G0, normal control rats; G1, acetaminophen induced hepatotoxic rats; G2, silymarin pre-treated rats; G3, Moringa oleifera pre-treated rats.